Zhu Bin, Zhu Cai-Feng, Lin Yi, Perkovic Vlado, Li Xian-Fa, Yang Ru, Tang Xuan-Li, Zhu Xiao-Ling, Cheng Xiao-Xia, Li Qiang, Chen Hong-Yu, Sun Yue, Chen Qian-Wen, Wang Yong-Jun
Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine (Guangxing Hospital), Zhejiang Chinese Medical University , Hangzhou, Zhejiang Province , China .
Ren Fail. 2015 Apr;37(3):424-32. doi: 10.3109/0886022X.2014.994408. Epub 2014 Dec 24.
C4 deficiency is the most commonly inherited immune disorder in human. The present study investigated the characteristics of the IgAN patients with low serum C4 levels.
We performed a prospective observational study. Clinical as well as histopathologic parameters were assessed. A Kaplan-Meier survival analysis was performed concerning the primary outcome defined as the serum creatinine increased 1.5-fold from baseline. The prognostic significances of clinical and histopathologic parameters were determined using Cox proportional hazards models.
Five-hundred twelve biopsy proven IgAN cases were available for analysis with a median follow-up of 38.4 months. Ninety-nine cases (19.34%) presented with low C4 levels (LowC4 group) and the other 413 cases did not (NlowC4 group). At the time of renal biopsy, renal injury was lighter in the LowC4 group compared with the NlowC4 group. Renal C4 deposition was significantly decreased while IgM deposition was increased in the LowC4 group. A correlation analysis shows that lower C4 levels were associated with better renal presentations at biopsy. However, the risk of developing the primary outcome was significantly greater in those with low C4 levels. Specifically, during the follow-up period, the risk of developing primary outcome was nearly ten folds higher in those with low C4, compared to those without low C4.
There is a high prevalence of low C4 levels in IgAN patients. These patients with low C4 levels exhibited better renal presentations at the time of renal biopsy, whereas might be associated with a poor prognosis.
C4缺乏是人类最常见的遗传性免疫疾病。本研究调查了血清C4水平低的IgA肾病患者的特征。
我们进行了一项前瞻性观察研究。评估了临床和组织病理学参数。对定义为血清肌酐从基线水平升高1.5倍的主要结局进行了Kaplan-Meier生存分析。使用Cox比例风险模型确定临床和组织病理学参数的预后意义。
512例经活检证实的IgA肾病病例可供分析,中位随访时间为38.4个月。99例(19.34%)C4水平低(低C4组),其他413例C4水平不低(非低C4组)。在肾活检时,低C4组的肾损伤比非低C4组轻。低C4组肾C4沉积显著减少,而IgM沉积增加。相关性分析表明,较低的C4水平与活检时较好的肾脏表现相关。然而,C4水平低的患者发生主要结局的风险显著更高。具体而言,在随访期间,C4水平低的患者发生主要结局的风险是非低C4患者的近10倍。
IgA肾病患者中C4水平低的患病率很高。这些C4水平低的患者在肾活检时肾脏表现较好,但可能预后较差。